Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
22.04.2025 13:02:02
|
Quest Diagnostics Updates EPS Outlook For FY25, Stock Down In Pre-Market
(RTTNews) - Quest Diagnostics Inc. (DGX), Tuesday announced revised outlook for the financial year 2025.
The company now sees earnings between $8.62 and $8.87 per share instead of previously estimated $8.34 and $8.59 for the full year 2025.
Meanwhile, it anticipates adjusted earnings of $9.55 to $9.80 per share, and revenue of $10.70 billion to $10.85 billion for the same period.
Analysts, on average, estimates earnings of $9.69 per share, and revenue of $10.78 billion for the fiscal year 2025.
In the pre-market hours, DGX is trading at $163.15, up 0.80 percent on the New York Stock Exchange.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 154,95 | 0,52% |
|